Wild Wisdom

Evaluate Wild Wisdom

Medspa consultation conversion software

Wild Wisdom is conversion intelligence for medical aesthetics. For one treatment line it determines whether demand, conversion or deliverable capacity is the binding constraint, explains why, states what would change that conclusion, tests an intervention where one is warranted, and closes the decision: continue, change or stop. If you are looking for medspa consultation conversion software, this page answers the questions a buyer asks, in order, with the product’s own screens beside each answer. It sits above your EMR, CRM and booking system and replaces none of them.

Published · By Wild Wisdom · Every screen and figure below is a synthetic sample

What software helps a medspa turn consultations into completed treatments?

Wild Wisdom is conversion intelligence for medical aesthetics. It is designed for operators who need to know where the next dollar on one treatment line should go. Before it looks at conversion at all, it establishes which of three constraints should govern the decision: demand, where not enough appropriate demand is reaching the line; conversion, where appropriate patients reach the consultation but clinician-approved plans do not progress through booking, completed treatment and continuation as expected; or deliverable capacity, where demand exists but qualified provider, device, room and time combinations cannot deliver enough appropriate treatment. It does not assume one of them. It evaluates them.

Where conversion is the constraint that binds, its workflow connects patient-stated barriers, the clinician’s recommendation and an operator’s review of what happened next. For consultation conversion, evaluate three things separately: where the journey stopped, what the patient said was in the way, and what response the clinic tested. A count of unbooked consultations does not establish whether the reason was cost, uncertainty, timing or a decision not to proceed — nor whether conversion was the right thing to work on.

Use the public product walkthrough to inspect the workflow. The current public examples use synthetic data on the product that runs today. They show what the product does and what it reports, not evidence that it has increased a clinic’s conversion rate. What each of the systems a clinic already runs does, and what conversion intelligence adds beside it, is set out in what is conversion intelligence for medical aesthetics.

Category
Conversion intelligence for medical aesthetics
Form
Web product: an operator console where each decision is investigated and recorded, a clinician workspace, and a patient Decision Room — the patient’s own treatment-decision record, opened by link. No app to install.
Decision it answers
Which of demand, conversion or deliverable capacity should govern the next operating decision on one treatment line
Unit of work
One decision per treatment line and primary location; one Decision Room per consultation where conversion is implicated
Data model
An append-only, signed record of each journey and each decision from intent to close; nothing is edited or deleted
Commercial model
A paid engagement — the scoped investigation: one treatment, one primary location, one consequential decision. At least twelve complete weeks of buyer-approved aggregate baseline, then thirty measured days.
Deliverable
An executive decision record: the reconciled baseline, the competing-constraint assessment, the binding and non-binding read, evidence and provenance, the economic range the data supports, the test where warranted, the close of continue, change or stop, the limitations, what would change the conclusion, the retest trigger, and the append-only history
Status
Inspect today: a synthetic demonstration, on this site and in the gated Operator Decision Room. Commission today: the scoped investigation. Real operating evidence enters Wild Wisdom only within an agreed engagement, once its data-handling boundary has been approved in writing. No customer engagement has yet been completed, so nothing on this site is customer evidence.

Can one clinic run a scoped investigation without an EMR integration?

A Wild Wisdom scoped investigation — the engagement previously called, and still often searched for as, a Conversion Pilot — is scoped to one treatment line, one primary location and one consequential decision: which of demand, conversion or deliverable capacity should govern what the clinic does next. The documented workflow does not require a live EMR, CRM or booking-system integration. Existing practice systems remain in use, and the clinic supplies the agreed aggregate baseline — at least twelve complete weeks — and the follow-through information.

A single-clinic owner can evaluate one pathway without assuming an enterprise rollout. A group operator can begin with one location before deciding whether the method is useful elsewhere. Results from different locations should not be pooled without accounting for treatment mix, observation periods and the number of eligible consultations.

Before an engagement starts, the written scope should specify the observation window, staff responsibilities, data inputs, deliverables, fee and stop/continue criteria. The public demonstration does not establish the time required in a live clinic or the commercial return. Those are questions for the engagement to measure.

Operator
COO, practice manager or owner of a clinic or group. Configures the engagement, opens rooms, reads the console, decides what to test next.
Clinician
Records what they recommend and why, and what they would not recommend and why not, in their own words. Retains every clinical decision.
Patient
Receives a private link to their Decision Room before and after the consultation. Sees their provider’s recommendation, not a menu.
Single location
One treatment line, one consequential decision, one observation window. The scope is the same as for a group.
Multi-location group
Begin with one location; compare locations only with like treatment mix, periods and eligible-consultation counts.
Not for
Clinics without a consultation step, lead-generation agencies, or anyone wanting a system that recommends treatments.

Which conversion problems does it identify?

First, which of the three constraints is the problem: demand, conversion or deliverable capacity. Only where conversion is the one that binds does the question become which conversion problem — and then there are eight reasons a patient who wants the outcome does not book, complete or continue, recorded in the patient’s own words and coded so they can be counted across every room. The reasoning behind the eight, and why a booking report cannot tell them apart, is in why medspa patients don’t book after the consultation.

It also separates the four things a conversion rate blends: intent, booking, completed treatment and continuation, and shows where between them the journey leaks.

  1. “I do not understand which treatment is right for this.”Treatment ambiguity
  2. “I am not sure what result I would actually get.”Outcome uncertainty
  3. “I am not sure who to trust.”Trust
  4. “I feel like I am being sold to.”Sales pressure
  5. “The cost is hard to justify right now.”Affordability
  6. “I am worried about recovery time.”Downtime
  7. “I am not sure this is the right provider for me.”Provider fit
  8. “I did the first session and never booked the next.”Continuation

What does the patient experience?

A private Decision Room, read on a phone. Before the consultation it asks what they hope for, what is making the decision hard, and how confident they feel about deciding. If the operator has switched it on, a two-minute Decision Story chosen for the concern they named.

After the consultation, their provider’s recommendation in the provider’s own words, with what the provider would not recommend; where enabled, Outcome Confidence, three relevant treatment journeys shown over time with their variation intact; the same confidence question again; what is still in the way; and, only where the clinic has authorised it and the patient has said cost or timing is the obstacle, one flexible appointment at a clinic-set price. Then a decision: book, more information, not now, or not for me. Every answer is a good answer.

Wild Wisdom

Decision Room

  1. You
  2. Understanding
  3. Your provider
  4. Where you stand
  5. Your decision
  6. Your journey

Before your consultation

Let us start with what you are hoping for.

There are no wrong answers here. This is so your provider can meet you where you actually are, rather than guessing.

Which of these is closest?

Prepared for a consultation at Calder Aesthetics Group.

Synthetic demonstration. Nothing here is about a real person, and nothing here is medical advice.

Decision Room · before the consultation · product interface · synthetic data

Wild Wisdom

Decision Room

  1. You
  2. Understanding
  3. Your provider
  4. Where you stand
  5. Your decision
  6. Your journey

Before you look

How sure are you that you understand what a realistic treatment journey could look like?

What the journey can look like

Three journeys that resemble yours.

  • Journey one3 sessions

    Texture changed first; tone followed over the series.

  • Journey two4 sessions

    Partial change at eight weeks. The provider extended the series.

  • Journey three2 sessions

    Stopped early by choice; the record shows why.

Synthetic journeys, for demonstration. In the product each one is a clinician-reviewed record with its variation intact, and “Why am I seeing this?” explains the match.

Prepared for a consultation at Calder Aesthetics Group.

Synthetic demonstration. Nothing here is about a real person, and nothing here is medical advice.

Outcome Confidence · after the recommendation · product interface · synthetic data

How does Wild Wisdom fit among patient education tools?

Patient education tools can serve different jobs: explaining treatments, showing visual examples, preparing patients for consultations or measuring understanding. The right choice depends on which job the clinic needs and the content available for its treatment lines.

Wild Wisdom’s documented approach connects selected educational experiences with patient-reported uncertainty and subsequent treatment follow-through. Its public examples do not establish a comprehensive education library, coverage of every treatment or superior results compared with another product.

For evaluation, inspect the education and confidence workflow, the content’s clinical review, the questions asked and the information returned to the operator. Confirm the material available for the proposed engagement before choosing a tool.

Explaining treatments
Decision Stories: short, shown before the consultation where the engagement enables them. Today there is one concern-specific story (uneven tone and texture) and a general consultation story shown for every other concern; coverage of every concern or treatment is not established.
Showing what to expect
Outcome Confidence: relevant journeys over time with their variation intact, clinician-reviewed. No prediction for an individual.
Measuring understanding
A quick check after the story and a before-and-after understanding question. Patient responses, not a validated clinical instrument.
What it returns to the operator
Which module was shown, whether it was completed, the answers given, and what happened at later stages

What does the provider experience?

A consultation page that shows what the patient said, in their words, and one form: what I recommend, why, what I would not recommend, why not. Submitted once, attributed to the clinician, and from then on part of the record. Wild Wisdom never proposes a treatment, scores suitability or predicts a result.

Clinicians can also review the outcome journeys shown to patients and record real, consented evidence into the library, with the relevance rules and consent scopes visible to them.

Wild Wisdom

Decision Room

  1. You
  2. Understanding
  3. Your provider
  4. Where you stand
  5. Your decision
  6. Your journey

What your provider recorded

Your provider recommends RF Microneedling.

These are your provider’s own words, recorded after your consultation. Wild Wisdom shows them to you; it did not write them and does not make recommendations.

Why

What I saw is mostly surface texture with some sun-related tone change on top. RF microneedling works below the surface and asks the skin to rebuild, which addresses both together.

What they would not recommend for you, and why not

Not light-based treatment

Light-based treatment would help the spots but would do very little for the texture you are most bothered by.

Your provider at Calder Aesthetics Group

Prepared for a consultation at Calder Aesthetics Group.

Synthetic demonstration. Nothing here is about a real person, and nothing here is medical advice.

What the patient sees of the provider’s record · product interface · synthetic data
Clinical Sincerity
Recommended and not-recommended, each with a reason, in the clinician’s words
Attribution
Every recommendation carries who made it and what the room knew at the time
Authority
The clinician determines clinical appropriateness. Nothing generated, nothing altered.
Time
One form after the consultation; reading what the patient said takes under a minute

What does the operator learn?

The top line is the binding constraint, not a friction. Read one at a time, the records explain a patient. Read across a cohort, they say which of demand, conversion or deliverable capacity is governing the line — and then, where conversion is the one that binds, where people fall out (conversion anatomy), why — from the cohort that actually lost (friction anatomy) — which intervention was shown and what happened after it, booked and completed minutes against a stated or derived ceiling, and what the decision in front of the clinic still commits in cash it can avoid.

A trust problem and an affordability problem look identical in a booking report. They do not look identical here, and each points at a different response. Don’t buy more leads for a conversion problem; don’t run a conversion test when capacity is the limit; don’t discount a trust problem.

Constraint brief · RF Microneedling · Highland Park

Synthetic sample · illustrative figures

  1. Demand

    NOT THE NEXT CONSTRAINT

    About 11.0 clinician-approved plans arrive each week and the line can deliver 10.7. Enough appropriate demand reaches this line for the decision in front of the partners. Demand is not the next constraint. Conversion governs the next dollar. If conversion improves, demand may become the next decision.

  2. Conversion

    BINDING

    Of 154 clinician-approved plans old enough to have booked, 88 did. The comparison this group set before we read anything was 80%. The gap is 22.9 points, or 4.7 bookings a week, above the materiality threshold of 1.5 completed treatments a week the COO approved.

  3. Deliverable capacity

    NOT BINDING

    No week in the last eight reached the booked-minutes threshold; the highest was 84%. There is room to deliver more — and closing the conversion gap is what would fill it.

What we checked

  • Consultations attended and clinician-approved plans, for 16 complete weeks
  • Bookings and completed treatments on the cohort that could have reached each step, not on activity in the period
  • Deliverable, booked and completed treatment minutes against a ceiling derived from the rota, the room schedule and the device log
  • The comparison rate this group set from its own other lines, and the materiality threshold approved before analysis
  • Patient-stated friction at readiness, for the cohort that did not book
  • Clinical declines, recorded separately and held out of every conversion denominator
What we know
Conversion is the binding constraint on this line for this period. About 11.0 clinician-approved plans arrive each week against 10.7 the line can deliver, and no week in the last eight reached the booked-minutes threshold, so neither demand nor deliverable capacity is what holds it back now. The loss is located between a clinician-approved plan and a booking, and outcome uncertainty is the friction most often still in the way for the patients who did not book.
What this does not tell you
Whether the intervention caused the difference between the two groups. Whether the three proposed locations would perform differently, which was not assessed. Anything about contribution or payback: the direct cost per completed treatment was not supplied, so no margin, ROI or payback figure appears anywhere in this record.
What would change our mind
If clinician-approved plans fell below what the line can deliver, demand would become the binding constraint and this conversion reading would be set aside. If booked minutes were sustained at Wild Wisdom's standing booked-minutes threshold, deliverable capacity would become binding and the rollout question would change shape. We re-read every period, and say so when it moves.

Recommended next step

Continue Outcome Confidence at the recommendation step on this line, and re-read the constraint at eight complete weeks.

A test was warranted here only because conversion is the binding constraint and the friction patients named has a response the clinician has already approved. Had capacity or demand been binding, the honest output would have been a decision and no test.

Investigation · RF Microneedling · Highland Park

Synthetic sample · illustrative figures

Binding constraint

Conversion

Approved-plan volume currently exceeds deliverable treatment capacity: about 11.0 clinician-approved plans arrive each week against 10.7 the line can deliver. Conversion is the material unresolved gap, so conversion is the constraint that should govern the next decision. No week in the last eight reached the booked-minutes threshold, so deliverable capacity is not binding either. The loss sits between a clinician-approved plan and a booking.

Where the loss sits

Approved plan → Booking

66 of 154 clinician-approved plans did not reach a booking: 57% against a 80% comparison this group set from its own other device-led lines. 23 points, or 4.7 bookings a week. Booked → completed held at 88%.

Patient-stated friction, inside conversion

Outcome uncertainty

Named at readiness by 18 of the 41 Decision Rooms opened among the 66 approved plans that did not book. Same cohort as the loss: these are the people who did not book, saying what was still in the way.

What closing the gap reaches

7.7 a week

At the 80% comparison rate, holding the observed 88% booked → completed rate. The original business case assumed 9 a week. Closing the conversion gap is the right next move and it does not, on its own, deliver the business case.

Deliverable capacity · not binding

84% peak week

Read against Wild Wisdom's standing capacity threshold over the last 8 weeks, reached in none of them. Utilisation 49% across the baseline. There is room to deliver more, and closing the conversion gap is what would fill it.

What the decision commits

$446,700

The uncommitted three-location rollout commitment, first twelve months: 3 locations at $148,900 each. Every line is avoidable cash at the date of this record: nothing is leased, ordered, offered or contracted. Sunk equipment cost, theoretical utilisation and the gross value of unbooked plans are not in it, because none of them is money a decision can still avoid.

Observational. Every figure is a count of what the Decision Graph recorded; no claim of causation is made, and no significance is computed.

What happens in a scoped investigation?

One treatment, one primary location, one consequential decision. The clinic supplies a baseline from its own records — at least twelve complete weeks of buyer-approved aggregates, reconciled before anything is read — and the three candidate constraints are read against the same period. Where the read warrants an intervention, the engagement is configured with the modules to switch on and Decision Rooms are opened for consultations in the period; where two variants are compared, the assignment mechanism is recorded before anything is shown and named as what it is — fixed, alternating or randomised. Where demand or deliverable capacity is the binding constraint, no intervention is recommended and none is run.

Every journey is followed through booking, treatment and continuation. Six integrity checks run over every room. At the close, a generated Conversion Review connects what changed to the treatment’s capacity economics, with a twelve-section printable pack behind it. Differences are described, not tested, and no claim of causation is made.

  1. Baseline
  2. Friction
  3. Intervention
  4. Booking
  5. Treatment
  6. Continuation
  7. Capacity economics

Wild Wisdom · Executive decision record

RF Microneedling, Highland Park

Calder Aesthetics Group · one treatment line · sixteen complete weeks, then thirty measured days

Sealed · append-only · 1 of 12

Wild Wisdom recommendation

CHANGE

Wild Wisdom recommends moving the rollout from a three-location approval to a staged approval, and holding the current three-location commitment this cycle pending the eight-week reread. The operating model being replicated has an unresolved constraint where it already runs, so this evidence does not justify approving the rollout as presented. Wild Wisdom assessed Highland Park only; the three proposed markets were not assessed and nothing here says anything about them.

  • CONTINUEOutcome Confidence at the recommendation step, on this line at Highland Park
  • CHANGEthe rollout from a three-location approval to a staged approval, gated on this line reaching the pre-agreed booking rate and on its capacity ceiling being raised
  • STOPthe current three-location rollout commitment this cycle — devices, fit-outs and hires — pending the eight-week reread

Leadership decision Not recorded in this sample. Leadership’s decision is recorded separately from Wild Wisdom’s recommendation.

Binding constraint

Conversion

Approved-plan volume currently exceeds deliverable treatment capacity: about 11.0 clinician-approved plans arrive each week against 10.7 the line can deliver. Conversion is the material unresolved gap, so conversion is the constraint that should govern the next decision. No week in the last eight reached the booked-minutes threshold, so deliverable capacity is not binding either. The loss sits between a clinician-approved plan and a booking.

Where the loss sits

Approved plan → Booking

66 of 154 clinician-approved plans did not reach a booking: 57% against a 80% comparison this group set from its own other device-led lines. 23 points, or 4.7 bookings a week. Booked → completed held at 88%.

Patient-stated friction, inside conversion

Outcome uncertainty

  • Outcome uncertainty18
  • Affordability11
  • Downtime7
  • Treatment ambiguity5

Deliverable capacity · not binding

84% peak week

Read against Wild Wisdom's standing capacity threshold over the last 8 weeks, reached in none of them. Utilisation 49% across the baseline. There is room to deliver more, and closing the conversion gap is what would fill it.

What closing the gap reaches

7.7 a week

At the 80% comparison rate, holding the observed 88% booked → completed rate. The original business case assumed 9 a week. Closing the conversion gap is the right next move and it does not, on its own, deliver the business case.

What we know

Conversion is the binding constraint on this line for this period. About 11.0 clinician-approved plans arrive each week against 10.7 the line can deliver, and no week in the last eight reached the booked-minutes threshold, so neither demand nor deliverable capacity is what holds it back now. The loss is located between a clinician-approved plan and a booking, and outcome uncertainty is the friction most often still in the way for the patients who did not book.

What this does not tell us

Whether the intervention caused the difference between the two groups. Whether the three proposed locations would perform differently, which was not assessed. Anything about contribution or payback: the direct cost per completed treatment was not supplied, so no margin, ROI or payback figure appears anywhere in this record.

What would change our mind

If clinician-approved plans fell below what the line can deliver, demand would become the binding constraint and this conversion reading would be set aside. If booked minutes were sustained at Wild Wisdom's standing booked-minutes threshold, deliverable capacity would become binding and the rollout question would change shape. We re-read every period, and say so when it moves.

What we tested, because the read warranted it

Does Outcome Confidence at the recommendation step change the share of clinician-approved plans that reach a booking?

Control · n = 23
57%
reached a booking · 13 of 23
Outcome Confidence · n = 24
71%
reached a booking · 17 of 24

Assignment mechanism: RANDOMISED, from a recorded seed sealed before any plan was assigned. Exposure delivered to 21 of 24, 88%, against a floor agreed at 80% beforehand. Observational: the 14.3-point difference is described, not tested. Bookings made inside the window need thirty-five days to reach a completed treatment, so their completion is outside this measurement and no revenue is claimed.

Next step

Continue Outcome Confidence at the recommendation step on this line, and re-read the constraint at eight complete weeks.

A test was warranted here only because conversion is the binding constraint and the friction patients named has a response the clinician has already approved. Had capacity or demand been binding, the honest output would have been a decision and no test.

Retest trigger

Re-read at eight complete weeks. Sooner if clinician-approved plans fall below what the line can deliver, which would make demand binding and set this reading aside.

What the decision commits

$446,700

The uncommitted three-location rollout commitment, first twelve months: 3 locations at $148,900 each. Every line is avoidable cash at the date of this record: nothing is leased, ordered, offered or contracted. Sunk equipment cost, theoretical utilisation and the gross value of unbooked plans are not in it, because none of them is money a decision can still avoid.

Observational. Associations are reported and no claim of causation is made. The decision, the constraint and the trigger are stated. Read at one location. Plano, Fort Worth and Austin were not assessed.

Synthetic sample · illustrative figures

What staff and data are required?

Less than most clinics expect. No integration is required for an engagement, the Decision Room asks a patient for no name or contact detail, and the clinic keeps every commercial term. What the engagement needs is one operator owner, clinicians willing to write their recommendation down, and a front desk that hands the patient a link. Real operating evidence enters Wild Wisdom only within an agreed engagement, once its data-handling boundary has been approved in writing.

People
One operator owner for the engagement; the clinicians consulting on the treatment line; front-desk staff who share the Decision Room link
Baseline data
An aggregate export for the period before: consultations, bookings, completions, prices, capacity hours. A CSV; fields with personal data are refused on import.
Configuration
Capacity hours per week, treatment minutes, providers and devices, standard price, and the flexible-access floor if used
Patient data
The patient’s own selections in a Decision Room, held under an opaque random reference; no name or contact detail is asked for. A live pilot adds real answers and clinician-approved outcome photographs, which can identify a person even without a name; both require agreed safeguards before any real record is accepted. Every record shown on this site is synthetic.
Systems
None connected. Your EMR, CRM and booking system run as before; Wild Wisdom does not read from or write to them.
Time
About one hour to configure; a few minutes per consultation for the clinician’s record; a review at the close

Can Wild Wisdom work alongside Aesthetic Record?

Wild Wisdom is designed to complement a clinic’s existing practice systems. For a clinic using Aesthetic Record, or any EMR, CRM or booking system, the relevant question is whether a separate patient-decision record adds useful information to the current consultation process.

The documented Wild Wisdom engagement has no connected practice systems. It should not be described as an Aesthetic Record integration, automatic synchronisation or a verified import workflow. Before evaluating the two together, agree how the clinic will supply baseline figures and record booking, treatment and continuation updates, who performs those steps, and how discrepancies will be reconciled.

If the existing process already captures the required reasons and follow-through reliably, another layer may not be necessary. An engagement should establish the additional decision value and staff effort.

EMR / practice management
Kept, unconnected. Records what was done. The clinic supplies booking, treatment and continuation updates by hand during an engagement.
CRM / marketing automation
Kept, unconnected. Sends messages. The engagement adds which reason the next message should answer.
Booking software
Kept, unconnected. Holds the diary. The engagement records what happened to patients who never reached it.
Treatment recommender
Not replaced and not used: Wild Wisdom makes no recommendation. The clinician’s own is recorded.
Marketing analytics
Kept. Measures leads to consultations. The engagement starts where that stops.

What can you inspect, commission and agree today?

You can inspect the product today. The Calder Aesthetics Group investigation on this site, and the gated Operator Decision Room demonstration, show what an engagement produces. Every figure in them is synthetic and labelled so everywhere it appears.

You can commission the scoped investigation today. Commercial terms and data requirements are established early in qualification and set out in the written scope.

Real operating evidence enters Wild Wisdom only within an agreed engagement, once its data-handling boundary has been approved in writing: what is shared and in what form, who handles it, how long it is kept, and how it is returned or deleted. Patient-level records — a patient’s Decision Room answers and clinician-approved outcome photographs — need their own safeguards agreed before any real record is accepted.

No customer engagement has yet been completed. Nothing on this site is customer evidence, no result here describes a real clinic, and the synthetic demonstration is not comparative performance evidence.

Inspect today
The synthetic Calder investigation on this site · the gated Operator Decision Room: one operating decision, the evidence behind it, and the recommendation and decision record. Access on request.
Commission today
The scoped investigation: one treatment, one primary location, one consequential decision, read across demand, conversion and deliverable capacity, closing with a decision record.
Agreed before real evidence
The written engagement scope · the data-handling boundary for operating evidence · separate safeguards before any patient-level record
Roadmap — intentions, not commitments
Anonymised benchmarks once sample sizes allow · further Decision Stories for other concerns · aggregate ingestion from common practice systems and analytics platforms · cross-location replication of a closed decision

What does Wild Wisdom deliberately not do?

The list is short and it is not a limitation; it is what makes the record trustworthy. A record of why patients hesitate is only useful if the thing they are hesitating over is a real clinical judgement, and if nothing in the room is selling.

  • It does not recommend treatments, score suitability, or predict a result for any patient.
  • It does not generate a confidence score. It asks the patient, twice, and records the answers.
  • It does not use facial analysis or any hidden model.
  • It does not send messages, set prices, book appointments or take payment.
  • It asks for no patient name or contact detail, and it does not read from or write to your systems. Answers under an opaque reference and outcome photographs are still personal data, and a live pilot requires agreed safeguards for them before any real record is accepted.
  • It does not call a variant a winner, and it does not claim causation from an engagement.

Read more

What is breaking in your patient journey?